|
Volumn 19, Issue 5, 2000, Pages 230-234
|
Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy
a a a a |
Author keywords
Brain; Glioblastoma; p53; Pathology; PCNA
|
Indexed keywords
CARMUSTINE;
CISPLATIN;
CYCLINE;
FORMALDEHYDE;
PARAFFIN;
PEROXIDASE;
PROTEIN P53;
STREPTAVIDIN;
TUMOR MARKER;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG RESPONSE;
FEMALE;
GLIOBLASTOMA;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MALE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
TUMOR GROWTH;
TUMOR SUPPRESSOR GENE;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
DISEASE PROGRESSION;
FEMALE;
GLIOBLASTOMA;
HUMANS;
MALE;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
PROLIFERATING CELL NUCLEAR ANTIGEN;
RADIOTHERAPY;
SURVIVAL RATE;
TUMOR MARKERS, BIOLOGICAL;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 0033816571
PISSN: 07225091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (26)
|